110 related articles for article (PubMed ID: 26876296)
1. Explaining differences in stakeholder take up of disease management programmes: A comparative analysis of policy implementation in Austria and Germany.
Schang L; Thomson S; Czypionka T
Health Policy; 2016 Mar; 120(3):281-92. PubMed ID: 26876296
[TBL] [Abstract][Full Text] [Related]
2. Overcoming fragmentation in health care: chronic care in Austria, Germany and The Netherlands.
Nolte E; Knai C; Hofmarcher M; Conklin A; Erler A; Elissen A; Flamm M; Fullerton B; Sönnichsen A; Vrijhoef HJ
Health Econ Policy Law; 2012 Jan; 7(1):125-46. PubMed ID: 22221931
[TBL] [Abstract][Full Text] [Related]
3. [General practitioners' opinion and attitude towards DMPs and the change in practice routines to implement the DMP "diabetes mellitus type 2"].
Miksch A; Trieschmann J; Ose D; Rölz A; Heiderhoff M; Szecsenyi J
Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):427-33. PubMed ID: 21843845
[TBL] [Abstract][Full Text] [Related]
4. Reported barriers to evaluation in chronic care: experiences in six European countries.
Knai C; Nolte E; Brunn M; Elissen A; Conklin A; Pedersen JP; Brereton L; Erler A; Frølich A; Flamm M; Fullerton B; Jacobsen R; Krohn R; Saz-Parkinson Z; Vrijhoef B; Chevreul K; Durand-Zaleski I; Farsi F; Sarría-Santamera A; Soennichsen A
Health Policy; 2013 May; 110(2-3):220-8. PubMed ID: 23453595
[TBL] [Abstract][Full Text] [Related]
5. Exploring payment schemes used to promote integrated chronic care in Europe.
Tsiachristas A; Dikkers C; Boland MR; Rutten-van Mölken MP
Health Policy; 2013 Dec; 113(3):296-304. PubMed ID: 23937868
[TBL] [Abstract][Full Text] [Related]
6. Some aspects of the reform of the health care systems in Austria, Germany and Switzerland.
Theurl E
Health Care Anal; 1999; 7(4):331-54. PubMed ID: 10787796
[TBL] [Abstract][Full Text] [Related]
7. Disease management programmes in Germany: a fundamental fault.
Felder S
Pharmacoeconomics; 2006 Dec; 24 Suppl 2():55-7. PubMed ID: 23389488
[TBL] [Abstract][Full Text] [Related]
8. Incentives in financing mental health care in Austria.
Zechmeister I; Oesterle A; Denk P; Katschnig H
J Ment Health Policy Econ; 2002 Sep; 5(3):121-9. PubMed ID: 12728199
[TBL] [Abstract][Full Text] [Related]
9. Identifying and explaining the variability in development and implementation costs of disease management programs in the Netherlands.
Tsiachristas A; Waters BH; Adams SA; Bal R; Mölken MP
BMC Health Serv Res; 2014 Oct; 14():518. PubMed ID: 25343967
[TBL] [Abstract][Full Text] [Related]
10. [Disease management programs between aspiration and reality. Actually, everything was meant to become much better].
Bullmann C; Straub C
Z Arztl Fortbild Qualitatssich; 2006; 100(1):32-5; discussion 36. PubMed ID: 16524227
[TBL] [Abstract][Full Text] [Related]
11. Disease management programmes for patients with coronary heart disease--an empirical study of German programmes.
Gapp O; Schweikert B; Meisinger C; Holle R
Health Policy; 2008 Dec; 88(2-3):176-85. PubMed ID: 18442868
[TBL] [Abstract][Full Text] [Related]
12. [Experiences with synopses of clinical guidelines using the example of synopses for Disease Management Programmes (DMP)].
Siering U; Rüther A
Z Evid Fortbild Qual Gesundhwes; 2014; 108(10):560-8. PubMed ID: 25499108
[TBL] [Abstract][Full Text] [Related]
13. [The quality of chronic care in Germany].
Fullerton B; Nolte E; Erler A
Z Evid Fortbild Qual Gesundhwes; 2011; 105(8):554-62. PubMed ID: 22142877
[TBL] [Abstract][Full Text] [Related]
14. Financial incentives for disease management programmes and integrated care in German social health insurance.
Greb S; Focke A; Hessel F; Wasem J
Health Policy; 2006 Oct; 78(2-3):295-305. PubMed ID: 16343688
[TBL] [Abstract][Full Text] [Related]
15. [Health economic evaluation of disease management programs].
Greiner W
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Jan; 49(1):34-9. PubMed ID: 16320012
[TBL] [Abstract][Full Text] [Related]
16. [Financial incentives for quality improvement].
Belicza E; Evetovits T
Lege Artis Med; 2010 May; 20(5):331-8. PubMed ID: 20533704
[TBL] [Abstract][Full Text] [Related]
17. Exploring Health System Responsiveness in Ambulatory Care and Disease Management and its Relation to Other Dimensions of Health System Performance (RAC) - Study Design and Methodology.
Röttger J; Blümel M; Engel S; Grenz-Farenholtz B; Fuchs S; Linder R; Verheyen F; Busse R
Int J Health Policy Manag; 2015 May; 4(7):431-7. PubMed ID: 26188807
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Disease Management Programs for Cardiovascular Risk and COPD in The Netherlands.
Tsiachristas A; Burgers L; Rutten-van Mölken MP
Value Health; 2015 Dec; 18(8):977-86. PubMed ID: 26686781
[TBL] [Abstract][Full Text] [Related]
19. Disease management programs in type 2 diabetes: quality of care.
Berthold HK; Bestehorn KP; Jannowitz C; Krone W; Gouni-Berthold I
Am J Manag Care; 2011 Jun; 17(6):393-403. PubMed ID: 21756010
[TBL] [Abstract][Full Text] [Related]
20. Report on financing the new model of family medicine.
Spann SJ;
Ann Fam Med; 2004 Dec; 2 Suppl 3(Suppl 3):S1-21. PubMed ID: 15654084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
